These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10549632)

  • 41. He who pays the piper, calls the tune....
    Brunekreef B
    Epidemiology; 2006 May; 17(3):246-7. PubMed ID: 16617268
    [No Abstract]   [Full Text] [Related]  

  • 42. Financial conflicts of interest in the National Institutes of Health?
    Maloney DM
    Hum Res Rep; 2004 Mar; 19(3):1-3. PubMed ID: 15139341
    [No Abstract]   [Full Text] [Related]  

  • 43. Development and marketing of new means of fertility control.
    American Public Health Association
    Am J Public Health; 1989 Mar; 79(3):352-3. PubMed ID: 11644366
    [No Abstract]   [Full Text] [Related]  

  • 44. American Society Of Clinical Oncology: revised conflict of interest policy.
    American Society of Clinical Oncology
    J Clin Oncol; 2006 Jan; 24(3):519-21. PubMed ID: 16365173
    [No Abstract]   [Full Text] [Related]  

  • 45. Pajaro Dunes Conference: draft statement.
    Pajaro Dunes Conference
    J Coll Univ Law; 1982-1983; 9(4):533-9. PubMed ID: 11650709
    [No Abstract]   [Full Text] [Related]  

  • 46. Ethical guidelines to publication of chemical research.
    Acc Chem Res; 2002 Jan; 35(1):74-6. PubMed ID: 11828979
    [No Abstract]   [Full Text] [Related]  

  • 47. Declaration of financial interests.
    Campbell P
    Nat Biotechnol; 2001 Oct; 19(10):892. PubMed ID: 11581637
    [No Abstract]   [Full Text] [Related]  

  • 48. U.S. research universities' institutional conflict of interest policies.
    Slaughter S; Feldman MP; Thomas SL
    J Empir Res Hum Res Ethics; 2009 Sep; 4(3):3-20. PubMed ID: 19754230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Oncology Nursing Society, ONS Foundation, and Oncology Nursing Certification Corporation Commercial Support Position.
    Oncol Nurs Forum; 2008 Mar; 35(2):163-4. PubMed ID: 18321826
    [No Abstract]   [Full Text] [Related]  

  • 50. Ethical responsibilities of physicians in their dealings with pharmaceutical companies.
    Royal College of Physicians and Surgeons of Canada. Biomedical Ethics Committee
    Ann R Coll Physicians Surg Can; 1990 Jan; 23(1):45-8. PubMed ID: 11650305
    [No Abstract]   [Full Text] [Related]  

  • 51. Policy on conflict of interest.
    Journal of Neurosurgery Publishing Group
    J Neurosurg Pediatr; 2008 Jan; 1(1):110-1. PubMed ID: 18352817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study on failures to disclose conflicts of interest in Environmental Health Perspectives.
    Goozner M
    Environ Health Perspect; 2004 Oct; 112(14):A794-5; author replies A795-7. PubMed ID: 15471711
    [No Abstract]   [Full Text] [Related]  

  • 53. Report from the Working Group of the Molecular Biology Society of Japan for the investigation of fraud in research papers.
    Tsurimoto T; Itoh T; Katayama T; Kimura H; Shinohara A
    Genes Cells; 2009 Aug; 14(8):903-8. PubMed ID: 19695023
    [No Abstract]   [Full Text] [Related]  

  • 54. Declaration of financial interests.
    Nat Cell Biol; 2001 Oct; 3(10):E219-20. PubMed ID: 11584279
    [No Abstract]   [Full Text] [Related]  

  • 55. Online disclosure of physician-industry relationships.
    Steinbrook R
    N Engl J Med; 2009 Jan; 360(4):325-7. PubMed ID: 19164185
    [No Abstract]   [Full Text] [Related]  

  • 56. Federal agency revises rule on financial disclosure by researchers.
    Maloney DM
    Hum Res Rep; 1999 Feb; 14(2):1-2. PubMed ID: 11657602
    [No Abstract]   [Full Text] [Related]  

  • 57. Embracing scrutiny.
    Goehl TJ
    Environ Health Perspect; 2004 Oct; 112(14):A788. PubMed ID: 15471707
    [No Abstract]   [Full Text] [Related]  

  • 58. Agency seeks approval of financial disclosure steps for researchers.
    Maloney DM
    Hum Res Rep; 2002 Mar; 17(3):1-2. PubMed ID: 12408150
    [No Abstract]   [Full Text] [Related]  

  • 59. Restraining sales reps bedevils materials managers.
    Barlow RD
    Hosp Mater Manage; 1992 Apr; 17(4):1, 11. PubMed ID: 10118331
    [No Abstract]   [Full Text] [Related]  

  • 60. Financial conflicts of interest worth knowing.
    Wray KB
    Science; 2010 Jan; 327(5962):144. PubMed ID: 20056873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.